___

• Grundy JE. Virologic and pathogenic aspects of cytomegalovirus infection. Rev Infect Dis 1990,12 (suppl 7):S 711-719.
• Rook Afl. Intractions of cytomegalovirus with the human immune system. Rev Infect Dis 1988; 1 Ofsuppl 3):S 460-467.
• Holland GTi, Repose JS, Pettit TH, Gottlieb MS, Yec RD, Roos RY. Aquaired immunodeficiency
• syndrome: ocular manifestation. Ophthalmol 1983;90:859-873.
• Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE and the Zidovudine Epidemiology Study Group. Incidence and natural history of CMV disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992;166:1223-1227.
• Başcıl H, Erdem Y, Yalçın AU, Hayran M, Haznedaroğlu İC. Evisceration of the eye in a renal transplant recipient with CMV chorioretinitis. Am J Tiephroi 1996; 16:367- 368.
• Ho M, Swansirikul S, Dowlings JH. The transplanted kidney as a source of cytomegalovirus infections. H Engl J Med 1975,293:1 109-1 1 12.
• Yossi Sid i karo, Larry Silver, Gary H. Holland, et al. Rhegmatogenous retinal detachments in patients with AIDS and necratizing retinal infections. Ophthalmol 1991;98:129-135.
• Freeman WR, Friedberg DM, Berry C, et al. Risk factors for development of rhegmatogenous retinal detachment in patients with CMV retinitis. AM J Ophthalmol 1993,116:713-720.
• Elkins SB, Holland GH, Opremcak EM, et al. Ocular toxoplasmosis misdiagnosed as CMV retinopathy in immunocompromised patients. Ophthalmol 1994;101:499-507.
• Emanual D, Cunningham I, Jules-Elysee K, et al. Cytomagalovirus pnumomonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high dse intraneous immunegloboline. Ann Intern Med 1988,109:777-782.
• Rubin RH, Rubin HEJ. Antimicrobial strategies in the care of organ transplan recipients. Antimicrob, Chmother 1993;37:619-624.
• Martin DF, Parks DJ, Mellow SD, et al. Treatment of CMV retinitis with an intraocular sustained release ganciclovir implant. Arch Ophthalmol 1994; 112:1531-1539.
• Smith TJ, Pearson PA, Bland ford DL, et al. Intravitreal sustained-release ganciclovir. Arch Ophthalmol 1992; 110-255-258.
• Sanborn GE, Anand R, Torti RE, et al.
• Sustained-release ganciclovir therapy for treatment of CMV retinitis: use of an
• introvitreal device. Arch Ophthalmol 1992,110:188-195.
• Lalezari JP, Stagg RJ, Ruppermann BD, et al. Intravenous cidofovir for peripheral CMV retinitis in patients with AIDS. Ann Int Med 1997;126:257-263.